Robert Kramer - Net Worth and Insider Trading
Robert Kramer Net Worth
The estimated net worth of Robert Kramer is at least $764,263 dollars as of 2025-04-27. Robert Kramer is the President and CEO of Emergent BioSolutions Inc and owns about 139,210 shares of Emergent BioSolutions Inc (EBS) stock worth over $764,263. Details can be seen in Robert Kramer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert Kramer has not made any transactions after 2021-02-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert Kramer
Robert Kramer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Kramer owns 2 companies in total, including Emergent BioSolutions Inc (EBS) , and Aptevo Therapeutics Inc (APVO) .
Click here to see the complete history of Robert Kramer’s form 4 insider trades.
Insider Ownership Summary of Robert Kramer
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2021-02-08 | Interim & EVP & BioSciences |
| APVO | Aptevo Therapeutics Inc | 2016-07-15 | director & President |
Robert Kramer Latest Holdings Summary
Robert Kramer currently owns a total of 1 stock. Robert Kramer owns 139,210 shares of Emergent BioSolutions Inc (EBS) as of February 8, 2021, with a value of $764,263.
Latest Holdings of Robert Kramer
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc | 2021-02-08 | 139,210 | 5.49 | 764,263 |
Holding Weightings of Robert Kramer
Robert Kramer Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Kramer has made a total of 3 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Emergent BioSolutions Inc is the sale of 45,397 shares on February 8, 2021, which brought Robert Kramer around $5 Million.
Insider Trading History of Robert Kramer
- 1
Robert Kramer Trading Performance
Robert Kramer Ownership Network
Ownership Network List of Robert Kramer
Ownership Network Relation of Robert Kramer
Robert Kramer Owned Company Details
What does Emergent BioSolutions Inc do?
Who are the key executives at Emergent BioSolutions Inc?
Robert Kramer is the Interim & EVP & BioSciences of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .
Emergent BioSolutions Inc (EBS) Insider Trades Summary
Over the past 18 months, Robert Kramer made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 22,919 shares made by Kathryn C Zoon , a net sale of 35,000 shares made by Neal Franklin Fowler , and a net sale of 25,000 shares made by Donald W Degolyer .
In summary, during the past 3 months, insiders sold 45,000 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 97,206 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 97,206 shares.
Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Emergent BioSolutions Inc Insider Transactions
Robert Kramer Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Kramer. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Robert Kramer's mailing address is: Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
